Showing results (71-80 of 305) with videos related to

Sort By:
Pageof 31
BJU International|July 6, 2013
The utility of prostate-specific antigen in the management of advanced prostate cancerE David Crawford, Charles L Bennett, Gerald L Andriole, et al.
The Prostate|July 18, 2015
Chronic baseline prostate inflammation is associated with lower tumor volume in men with prostate cancer on repeat biopsy: Results from the REDUCE studyDaniel M Moreira, J Curtis Nickel, Gerald L Andriole, et al.
Applied Health Economics and Health Policy|August 31, 2011
Cost effectiveness of chemoprevention for prostate cancer with dutasteride in a high-risk population based on results from the REDUCE clinical trialMichael W Kattan, Stephanie R Earnshaw, Cheryl L McDade, et al.
The Journal of Urology|April 17, 2012
Polysymptomatic, polysyndromic presentation of patients with urological chronic pelvic pain syndromeH Henry Lai, Carol S North, Gerald L Andriole, et al.
International Braz J Urol : Official Journal of the Brazilian Society of Urology|June 11, 2016
Prostate MRI: a national survey of Urologist's attitudes and perceptionsBrandon J Manley, John A Brockman, Valary T Raup, et al.
The Journal of Urology|August 8, 2006
The interpretation of serum prostate specific antigen in men receiving 5alpha-reductase inhibitors: a review and clinical recommendationsLeonard S Marks, Gerald L Andriole, John M Fitzpatrick, et al.
Urology|December 28, 2016
Extent of Baseline Prostate Atrophy Is Associated With Lower Incidence of Low- and High-grade Prostate Cancer on Repeat BiopsyDaniel M Freitas, Gerald L Andriole, Ramiro Castro-Santamaria, et al.
Urology|January 26, 2019
Management of Symptom Flares and Patient-reported Flare Triggers in Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)-Findings From One Site of the MAPP Research NetworkH Henry Lai, Joel Vetter, Joseph Song, et al.
The Journal of Urology|January 27, 2022
Survival Outcomes in Men with Unfavorable Intermediate-Risk and High-Risk Prostate Cancer Treated with Prostate-Only versus Whole Pelvic Radiation TherapyNeal Andruska, Benjamin W Fischer-Valuck, Michael Waters, et al.
Reviews in Urology|April 30, 2021
Low Penetrance Germline Genetic Testing: Role for Risk Stratification in Prostate Cancer Screening and Examples From Clinical PracticeFranklin Gaylis, Kelly K Bree, Paul Dato, et al.
Pageof 31